Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Curr Atheroscler Rep. 2011 Dec;13(6):461-6. doi: 10.1007/s11883-011-0201-4.
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an enzyme which binds to oxidized LDL and has a pro-inflammatory role in the pathogenesis of atherosclerosis. The Lp-PLA(2) Studies Collaboration showed the relationship between Lp-PLA(2) levels and activity with coronary heart disease and ischemic stroke. Levels and activity of Lp-PLA(2) are reduced by statins. There have been limited studies focused on dietary factors and effects on LpPLA(2). A recent article from the Nurses' Health Study (HNS) and the Health Professionals Follow-up Study (HPFS) has provided interesting insights. In this cross sectional study, a lower LpPLA(2) activity was found to be related to several dietary factors including higher percentage of energy consumed as protein instead of carbohydrate, mild to moderate intake of alcohol, higher mono-unsaturated fat intake instead of carbohydrate, and not being overweight. It is unknown whether changes in Lp-PLA(2) by diet alter cardiovascular risk.
脂蛋白相关磷脂酶 A2(Lp-PLA2)是一种与氧化型 LDL 结合的酶,在动脉粥样硬化的发病机制中具有促炎作用。Lp-PLA2 研究协作组表明 Lp-PLA2 水平和活性与冠心病和缺血性卒中之间存在关联。他汀类药物可降低 Lp-PLA2 水平和活性。目前,关于饮食因素及其对 LpPLA2 的影响的研究有限。最近一项来自护士健康研究(NHS)和健康专业人员随访研究(HPFS)的文章提供了有趣的见解。在这项横断面研究中,发现较低的 LpPLA2 活性与几种饮食因素有关,包括蛋白质而不是碳水化合物占能量摄入的比例更高、适度至中度饮酒、单不饱和脂肪而不是碳水化合物的摄入量更高,以及体重不过重。尚不清楚饮食对 Lp-PLA2 的改变是否会改变心血管风险。